Search
Search Results
-
Cognitive screening and rehabilitation after cardiac arrest: only a few hurdles to take
Dutch and European guidelines recommend systematic screening for cognitive and emotional impairments in cardiac arrest survivors. We aimed to clarify...
-
Prenatal Detection of Congenital Heart Disease: Importance of Fetal Echocardiography Following Normal Fetal Cardiac Screening
Fetal echocardiography may be performed because of noncardiac indications (the pregnancy is identified as high risk for fetal cardiac disease), or...
-
The Athlete’s ECG: The Potential Utility in Screening and Prevention of Sudden Cardiac Death
Purpose of ReviewThe purpose of the review is to discuss the role of the electrocardiogram (ECG) in screening and diagnostic evaluation for the young...
-
Comparison of Different Ultrasonic Screening Methods and Analysis of High Risk Factors for Fetal Cardiac Malformation in Second Trimester of Pregnancy
Current study aims to compare the application of two-dimensional (2D) color doppler ultrasound (CDU) and four-dimensional (4D) ultrasound...
-
Cascade screening can be life-saving: a family with multiple cases of brugada syndrome and sudden cardiac death
Brugada syndrome (BrS) may cause a spectrum of symptoms from asymptomatic patients to those who experience cardiac arrest and sudden cardiac death....
-
Post-mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study
Sudden cardiac death (SCD) might have an inherited cardiac condition background. Genetic testing supports post-mortem diagnosis and screening of...
-
Cardiac screening in pediatric patients with neurofibromatosis type 1: similarities with Noonan syndrome?
Both Neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are RASopathies. Characteristic cardiac phenotypes of NS, including specific...
-
Secondary cardiac lymphoma presenting with cardiac tamponade and cardiac mass: a case report
BackgroundCardiac tamponade as the presenting manifestation of systemic lymphoma is relatively uncommon. Pericardium is the commonest site of...
-
Depression screening in patients with coronary heart disease
In view of the large and sometimes conflicting body of research, this narrative review summarizes the current evidence on depression screening in...
-
Utility of fetal cardiac magnetic resonance imaging in assessing the cardiac axis in fetuses with congenital heart disease
BackgroundFetal dedicated echocardiography is the standard to measure the fetal cardiac axis. However, fetal screening ultrasound (US) or fetal...
-
Nonstructural Genetic Cardiac Disease as the Most Common Cause of Sudden Cardiac Death in the Young Athlete: Is This True?
Purpose of reviewThis review is aimed at summarizing and discussing the primary causes of sudden cardiac death (SCD) in young athletes.
... -
Cardiac disease-induced trauma and stress-related disorders
ObjectiveThis review aims to present an updated overview of cardiac disease-induced trauma and stress-related disorders such as acute stress disorder...
-
Diagnostic value of reversed differential cyanosis in (supra)cardiac total anomalous pulmonary venous return
BackgroundTo investigate the occurrence of reversed differential cyanosis (RDC) in case of (supra)cardiac total anomalous pulmonary venous return...
-
The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy
ObjectivesCardiac involvement is one of the most serious complications of idiopathic inflammatory myopathy (IIM) that indicates poor prognosis....
-
-
Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy
BackgroundCardiac hypertrophy, which develops in middle-aged and older individuals as a consequence of hypertension and obesity, is an established...
-
Serum markers in systemic sclerosis with cardiac involvement
Cardiac involvement in systemic sclerosis is a common clinical entity that may range from subclinical to life-threatening complications. The...
-
Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Purpose of ReviewCardiac myosin inhibitors (CMIs) and activators are emerging therapies for hypertrophic cardiomyopathy (HCM) and heart failure with...
-
Development of a short form of the Cardiac Distress Inventory
BackgroundCardiac distress may be viewed as a persistent negative emotional state that spans multiple psychosocial domains and challenges a patient’s...
-
Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance
BackgroundInherited cardiomyopathies (HCM, DCM, ACM) and cardiac ion channelopathies (long QT/Brugada syndromes, CPVT) are associated with...